Bicara Therapeutics Insider Sold Shares Worth $833,129, According to a Recent SEC Filing
Ryan Cohlhepp, Director, President and COO, on July 08, 2026, sold 28,750 shares in Bicara Therapeutics (BCAX) for $833,129. Following the Form 4 filing with the SEC, Cohlhepp has control over a total of 181,641 common shares of the company, with 181,641 shares held directly. SEC Filing:
Ryan Cohlhepp, Director, President and COO, on July 08, 2026, sold 28,750 shares in Bicara Therapeutics (BCAX) for $833,129.
Following the Form 4 filing with the SEC, Cohlhepp has control over a total of 181,641 common shares of the company, with 181,641 shares held directly.
SEC Filing: